Clinical Trial Update: Prothrombotic Inflammatory Markers in Women With Metabolic Syndrome - Effect of Atorvastatin [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/Phase 2 study evaluating atorvastatin's impact on prothrombotic inflammatory markers in women with metabolic syndrome, with results posted in 2017.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Metabolic Syndrome

Drugs mentioned

• atorvastatin (atorvastatin)

Snippet

Sponsor: University of Rochester | Conditions: Metabolic Syndrome | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2017-06-07